Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to pseudomonas aeruginosa

[1]  G. Jackson,et al.  Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis. , 1988, The American journal of medicine.

[2]  V. Andriole,et al.  Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis. , 1987, The Journal of infectious diseases.

[3]  G. Eliopoulos,et al.  Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats , 1987, Antimicrobial Agents and Chemotherapy.

[4]  Lance R. Peterson.  Animal models: the in-vivo evaluation of ciprofloxacin. , 1986, The Journal of antimicrobial chemotherapy.

[5]  I. Phillips,et al.  The comparative in-vitro activity of eight newer quinolones and nalidixic acid. , 1986, The Journal of antimicrobial chemotherapy.

[6]  M. Sande,et al.  Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. , 1986, The Journal of antimicrobial chemotherapy.

[7]  M. Dudley,et al.  Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model. , 1986, The Journal of antimicrobial chemotherapy.

[8]  K. Kim,et al.  Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. , 1986, The Journal of antimicrobial chemotherapy.

[9]  F. Follath,et al.  Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections , 1986, European Journal of Clinical Microbiology.

[10]  H. Giamarellou,et al.  Evaluation of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections , 1986, European Journal of Clinical Microbiology.

[11]  J. Pennington,et al.  Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia , 1986, Antimicrobial Agents and Chemotherapy.

[12]  R. Maserati,et al.  Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis , 1985, Antimicrobial Agents and Chemotherapy.

[13]  C. Norden,et al.  Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa. , 1985, The Journal of infectious diseases.

[14]  C. Norden,et al.  In vitro activity of ciprofloxacin against aerobic gram-negative bacteria , 1984, Antimicrobial Agents and Chemotherapy.

[15]  G. Eliopoulos,et al.  In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent , 1984, Antimicrobial Agents and Chemotherapy.

[16]  A. Chow,et al.  Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections , 1983, Antimicrobial Agents and Chemotherapy.

[17]  D. Goldmann,et al.  Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. , 1983, The Journal of infectious diseases.

[18]  G. Bodey,et al.  Infections caused by Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.

[19]  A. Lerner,et al.  Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.

[20]  R. Pearson,et al.  Method of reliable determination of minimal lethal antibiotic concentrations , 1980, Antimicrobial Agents and Chemotherapy.

[21]  M. Levison,et al.  Rat model of experimental endocarditis , 1978, Infection and immunity.

[22]  L. Garrod.  Forty years on. , 1975, The Journal of antimicrobial chemotherapy.

[23]  R. Moellering,et al.  Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. , 1971, The Journal of clinical investigation.

[24]  R. Moellering,et al.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. , 1971, The Journal of laboratory and clinical medicine.

[25]  A. Barry.  Susceptibility tests : diffusion test procedure , 1985 .

[26]  H. Neu.  The role of Pseudomonas aeruginosa in infections. , 1983, The Journal of antimicrobial chemotherapy.

[27]  P S Cohen,et al.  Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. , 1980, Progress in cardiovascular diseases.